Skip to content

Cancer IQ

1 viewer · 30d

Total raised

$4.3M

1 filing since 2023 · latest SAFE filed

Cumulative raised
LAST ROUND
SAFE · $4.3M
ROUNDS
1
INVESTORS
9
FOUNDED
N/A
HQ
Chicago, IL
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
1

AI overview

Updated

CancerIQ is a Chicago-based precision health software company founded in 2013 out of the University of Chicago. Its cloud platform helps hospitals and clinics identify patients at elevated cancer risk, stratify them using evidence-based guidelines such as NCCN and Tyrer-Cuzick, and move them through genetic counseling, testing, and follow-up screening. The software integrates with existing EHR systems and automates pedigree generation, care-plan creation, insurance pre-authorization documentation, and adherence tracking. The company reports deployment across 275+ clinic locations nationwide.

What sets it apart

Turns hereditary cancer risk assessment into an automated, EHR-integrated workflow rather than a manual genetic-counselor task, and reports measurable outcomes for health systems: 2.2x more completed genetic tests, 4.2x more supplemental screening, and an 8.9x average ROI.

Funding history

1 round
SAFE+2Nov 1, 2023
Form D/A
+$4.3M$4.3M total

Latest SEC filings

via EDGAR · CIK 0001810038
Form D/A · Nov 1, 2023View on EDGAR

Products

1 tracked

CancerIQ Platform

Clinical software platform

A precision health platform that lets providers identify, evaluate, and manage whole patient populations by individual genetic risk, then connect each patient to the right cancer prevention, screening, and diagnostic pathway.

  • Automated cancer risk assessment and patient stratification using NCCN and Tyrer-Cuzick guidelines
  • Automated family history pedigree generation
  • Genetic testing marketplace integration and insurance pre-authorization documentation
  • Personalized care plan creation with screening and follow-up alerts

Links

WebsiteLinkedInSEC EDGAR filings